Clinical effects of continuous theta burst stimulation for generalized anxiety disorder and a mechanism involving α oscillations: a randomized controlled trial

From the Department of Neurology, the Second Hospital of Dalian Medical University, Dalian, China (Li, Tan, Ding, C. Wang, M. Wang, Lin); the Stem Cell Clinical Research Institution, the First Affiliated Hospital of Dalian Medical University, Dalian, China (Li); the Clinical Drug Trial Institution, the Second Hospital of Dalian Medical University, Dalian, Liaoning Province, China (Zhang)

From the Department of Neurology, the Second Hospital of Dalian Medical University, Dalian, China (Li, Tan, Ding, C. Wang, M. Wang, Lin); the Stem Cell Clinical Research Institution, the First Affiliated Hospital of Dalian Medical University, Dalian, China (Li); the Clinical Drug Trial Institution, the Second Hospital of Dalian Medical University, Dalian, Liaoning Province, China (Zhang)

From the Department of Neurology, the Second Hospital of Dalian Medical University, Dalian, China (Li, Tan, Ding, C. Wang, M. Wang, Lin); the Stem Cell Clinical Research Institution, the First Affiliated Hospital of Dalian Medical University, Dalian, China (Li); the Clinical Drug Trial Institution, the Second Hospital of Dalian Medical University, Dalian, Liaoning Province, China (Zhang)

From the Department of Neurology, the Second Hospital of Dalian Medical University, Dalian, China (Li, Tan, Ding, C. Wang, M. Wang, Lin); the Stem Cell Clinical Research Institution, the First Affiliated Hospital of Dalian Medical University, Dalian, China (Li); the Clinical Drug Trial Institution, the Second Hospital of Dalian Medical University, Dalian, Liaoning Province, China (Zhang)

From the Department of Neurology, the Second Hospital of Dalian Medical University, Dalian, China (Li, Tan, Ding, C. Wang, M. Wang, Lin); the Stem Cell Clinical Research Institution, the First Affiliated Hospital of Dalian Medical University, Dalian, China (Li); the Clinical Drug Trial Institution, the Second Hospital of Dalian Medical University, Dalian, Liaoning Province, China (Zhang)

From the Department of Neurology, the Second Hospital of Dalian Medical University, Dalian, China (Li, Tan, Ding, C. Wang, M. Wang, Lin); the Stem Cell Clinical Research Institution, the First Affiliated Hospital of Dalian Medical University, Dalian, China (Li); the Clinical Drug Trial Institution, the Second Hospital of Dalian Medical University, Dalian, Liaoning Province, China (Zhang)

From the Department of Neurology, the Second Hospital of Dalian Medical University, Dalian, China (Li, Tan, Ding, C. Wang, M. Wang, Lin); the Stem Cell Clinical Research Institution, the First Affiliated Hospital of Dalian Medical University, Dalian, China (Li); the Clinical Drug Trial Institution, the Second Hospital of Dalian Medical University, Dalian, Liaoning Province, China (Zhang)